Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

The explanation for this treatment involves the cholinergic nervous system. The German scientists point out that SARS-CoV-2 ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Covid.gov and covidtests.gov were established during the COVID-19 pandemic as resources for the public to order tests and ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Trump said on Tuesday COVID will not, however, feature in trade negotiations, saying he wouldn't "play hardball" with China.

Scientists reveal what vaccines are really capable of As new COVID-19 variants continue to emerge, widespread concerns have ...

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

Public health researchers untangle two decades of maternal mortality data and finds that while early increases were driven by ...